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I n tr o d u c tio n .
One of the major problems facing the health 
service in any country which has a high preva­
lence of bilharziasis is the shortage of medical 
personnel required for the successful treatment 
of the large numbers of people who show infec­
tion. However, if a totally safe regime involving 
the administration of relatively innocuous drug 
at low dosages over long periods of time to con­
trol or suppress the level of infection in the 
person, the administration of the drug could 
then be left to the teachers or to other respons­
ible members of the community. It is in this 
context that the policy of suppressive therapy 
or management of schistosome infections shows 
its greatest attraction.
The original concept of “ suppressive manage­
ment”  in the control of bilharziasis as suggested 
by Friedheim and de Jong (1959), by Davis 
(1961) and by Jordan and Randall (1962) 
made use of the drug TWSb-antimony di-mer- 
capto-succinate (Astiban) w h i c h  required 
parental administration. McMahon (1966) in­
vestigated the suppressive effect of niridazole 
(Ambilhar, CIBA) and lucanthone hydrochlor­
ide (Nilodin, B.W. and C o .) . He concluded 
that the latter named drug was ineffective in 
the doses given, but that niridazole was more 
promising. The dose of lucanthone hydrochlor­
ide given was only 250 mg in the group in which 
he was able to obtain adequate follow-up 
results. Niridazole was given at a dose of 25 
m g/kg at weekly intervals for eight weeks and 
he obtained a 45 per cent, reduction in urine 
egg output. Kilala (1966) also used niridazole 
at a dose rate of 25 m g/kg per week for only 
five weeks and he obtained a -20 per cent, re­
duction in urine egg output, and noted that the 
reduction was more noticeable in children with 
heavier egg loads.
McMahon (1967) compared niridazole at a 
dose of 35 mg/kg twice weekly for six weeks 
with a group treated with lucanthone hydro­
chloride at a dose of 500 mg once weekly for 10
SUPPRESSIVE THERAPY
f weeks. He obtained a reduction of 72 and 89 
' per cent, respectively, in the excretion of Schis­
tosoma mansoni eggs in the stool. He con­
sidered drug resistance not to be a problem in 
bilharziasis and no evidence that suppressive 
therapy affected the immune response. In his 
opinion suppressive therapy is a justifiable form 
of treatment in endemic areas with high infec- 
tivity in that it would reduce tissue damage in 
the human host.
The most encouraging results were those re­
ported by Lees (1968) following his trial of 
lucanthone hydrochloride in suppressive treat­
ment of S. mansoni infections in school children 
in St. Lucia. Giving 500 mg of the drug once 
weekly for 10 weeks he obtained a mean reduc­
tion of egg output of virtually 90 per cent., 26 
and 36 weeks after the end of the treatment. 
He obtained an overall parasitological cure in 
37 per cent, of the patients, these being children 
with light infections who were excreting less 
than 10 000 eggs. The drug was administered 
by a qualified nurse and no significant side 
effects were noted.
It is accepted that S. haematobium infections 
are more easily cured than those caused by S. 
mansoni and this seems to be so whatever drug 
is used. If Lees’ results could be confirmed 
under African conditions, a programme of sup­
pressive management would have wide applica­
tion in the treatment of vast numbers of school 
children showing both S. haematobium and S. 
mansoni infections. With these indications in 
mind, it was decided to attempt a comparative 
trial of lucanthone hydrochloride (Nilodin, 
B.W. and G o.), niridazole (Ambilhar, GIBA) 
and oral hycanthone (Win —  24, 933-2) in the 
suppressive management of S. haematobium 
and S. mansoni infections in a locality of high 
transmission of bilharziasis.
Pr o g ram m e  for  t h e  T r ial .
An African primary school in- the Mazoe 
Valley, 30 miles north-west of Salisbury, was 
selected for the trial. The school, which has 
an enrolment of nearly 500 pupils, is situated 
on the banks of the Mazoe River and is near 
a system of irrigation canals. Although the 
school has a purified piped water, supply and 
adequate sanitary facilities, the children have 
ready access to the river and other infected 
waterways, and transmission of bilharziasis to 
this community would be high before, during 
and after the period of the drug trial. In Feb­
ruary, 1969, a stool and urine survey was carried 
out on all the children attending the school. All 
material was examined by the methods advo­
cated by Blair et al (1969a and b ) ; urine egg 
counts, stool egg estimations and hatching of
miracidia were done on urine and stool speci­
mens to determine the viability of the infection 
in each subject. A full record of names, sex, 
age and weight was made so that each child 
could be confidently identified at each of the 
subsequent drug administrations which were 
given weekly for 10 weeks from 24th February 
to 28th April, 1969.
The pre-treatment parasitological survey 
showed 442 children infected with either 
S. haematobium, S. mansoni or with both para­
sites and, in fact, only 29 children in the' whole 
school were found free of parasitological evi­
dence of bilharziasis.
For practical reasons the infected children 
in the two senior grades of the school were set 
aside for treatment with intramuscular hycan 
thone (Etrenol, Winthrop). A total of 60 bo7s 
and girls were given a single intramuscular in­
jection of this drug at a level of 3 m g/kg on 
10th March, 1969. The remaining infected 
children were allotted to one of four groups, 
selected so that each group contained an equal 
proportion of children of each sex and' the 
various age groups and to obtain as even a 
spread as possible of heavy S. mansoni infec­
tions, light S. mansoni infections, heavy S. hae­
matobium infections, light 51. haematobium in­
fections and double infections in each group. 
Allocation of children to receive oral medication 
into four groups was arranged because it was 
originally hoped to have two groups receiving 
lucanthone hydrochloride, both groups for the 
first term of 1969 (10 weeks) and one of these 
to receive the same course of treatment in the 
third term of the year. In the event, the results 
were so disappointing that in the analysis of the 
results, the two lucanthone hydrochloride 
groups have been amalgamated and the second 
group not re-treated in the third term. A few 
children were lost to the trial after the initial 
survey so that when drug administration on a 
weekly basis started Group A comprised. 181 
children each receiving two 250 mg tablets of 
uncoated lucanthone hydrochloride as a single 
dose each week for 10 weeks; Group B consisted 
of 92 children who were to receive two 500 mg 
tablets of niridazole as a single dose each for 
10 weeks, and Group G contained 92 children 
who were to have been given two 50 mg enteric 
coated tablets of hycanthone (Win 24, 933-2) 
as a single dose each week for 10 weeks; Side 
effects and serious absenteeism after the ad­
ministration of the first dose of oral hycanthone 
prompted a reduction of the weekly dose to one 
50 mg tablet. Follow-up surveys were carried 
out at 5, 12 and 19 weeks after the administra­
tion of intramuscular hycanthone and at 6 and 
13 weeks after the completion of the 10 weeks 
of treatment for children receiving oral drugs.
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Table I.
Age Group in Years
7-9 10-12 13-15 16-20 Total
S. haematobium 
Males:
Number examined 100 119 76 7 302
Number positive 61 95 50 5 211
Percentage positive 61 80 66 — 70
Females:
Number examined 79 68 20 2 169
Number positive 60 53 15 1 129
Percentage positive 76 78 75 — 76
Total:
Number examined 179 187 96 ' 9 471
Number positive 121 148 65 6 340
Percentage positive 68 79 68 — 72
S. mansoni 
Males:
Number examined 103 120 77 7 307
Number positive 73 91 58 5 227
Percentage positive 71 76 75 — 74
Females:
Number examined 70 71 20 2 163
Number positive 54 58 15 2 129
Percentage positive 77 82 75 — 79
Total:
Number examined 173 191 97 9 470
Number positive 127 149 73 7 356
Percentage positive 73 78 75 — 76
Distribution ofS.  mansoni infections:
Cases S. mansoni only 43 31 25 3 102
Double infections S. haematobium
and S. mansoni 85 119 48 4 256
R e s u l t s .
The analysis of the pretreatment survey is 
set out in Table I. Boys outnumbered the girls, 
but the latter had slightly higher prevalence of 
both forms of bilharziasis. It is unusual in 
Rhodesia to have a higher prevalence of S. man- 
soni infections as is the case in this trial. The 
majority of the children were in the age groups 
-7 to 15 years and only nine children were 16 
years and over.
Efficiency of drug dosing:
Not all the children took the full course of 
ten doses of the oral drugs. The main reason 
for this was that because of the time expended 
in carrying out the initial prevalence survey 
and in arranging the allocation groups, the last 
two doses had to be administered during the 
school holidays. During the first eight weeks 
the number of children treated each Monday 
morning ranged from 364 on the first round to
34
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Table II.
Perfo rm an ce  of C h ild ren  in  T a k in g  T h e ir  D ose  of D rugs A dm in ister e d .
Number of Doses Taken
Gone away Total
All 10 9 8 7 6 less than 6
from school
A 35 40 52 32 15 5 2 181
B 20 18 32 11 6 5 1 93
C 26 11 27 19 9 0 2 94
% taking six 
doses or more 
(353 pupils)
81
23,0
69
19,5
111
31,4
62
17,6
30
8,5
10 5 368
Table III.
I m m ediate  Pa t ie n t  R eaction  to  D o s in g .
Group
No. of 
children 
affected
No. of doses 
vomited or 
rejected
Children who vomited or rejected No. of- 
tablets not 
takenOne dose Two doses Three doses Five doses
A 31 54 18 7 5 i 99
B 5 8 4 — 1 — 13
C 4 5 3 1 — — 5
318, while on the ninth and tenth dosing days 
only 157 and 123 children were treated, respec­
tively. Over the 10-week period the maximum 
number of doses for the four oral drug groups 
was 3 680, but only 3 012 were administered —  
82 per cent. Considering only the first eight 
weeks of drug administration which took place 
in term-time, 2 732 out of a possible 2 944 (93 
per cent.) were administered. There was no 
difference between the performance of the 
children in one group as compared with the 
others, and considering the first eight weeks of 
treatment the percentage efficiency of dose 
taking for Groups A, B and C was 92, 94 and 
93, respectively. Thus the foul taste of lucan- 
thone hydrochloride did not seem to have dis­
couraged children from coming to school and 
taking the next dose. Table II shows the num­
ber of children in each group who took six or 
more doses. The proportions are roughly the 
same for each drug.
Reaction to the drugs'. (Immediate) :
A study was made of the immediate patient 
reaction to the drugs and these are shown in 
Table III. It will be noted, that the vomiting 
of drug and the rejection of the second tablet
after the first had been vomited, vvas most 
obvious in Group A (lucanthone hydrochlor­
ide) , and these children tended to go on vomit­
ing on subsequent attendances. The number of 
children taking niridazole and hycanthone fared 
much better. The problem of immediate vomit­
ing and gagging of lucanthone hydrochloride 
meant that after the first week drug adminis­
tration had to be carried out under the shade 
of trees in the playground otherwise the floors 
of the class-rooms would have been fouled with 
vomit.
Drug toxicity.
Toxicity as opposed to vomiting and immedi­
ate rejection of the drug was rare, and few of 
the children showed little more than nausea or 
vomiting in the evening of the day the drug was 
administered. Table IV  shows the later re­
actions to the drugs, and the effect on school 
attendance on the days following the adminis­
tration of the drug. It is interesting to see that 
oral hycanthone caused more school absence 
and affected more children in the group than 
did lucanthone hydrochloride, considering that 
nearly twice as many children were at risk in 
the latter drug group.
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Effect of treatment on urine egg output:
The method of examination of urine speci­
mens for eggs of S. haematobium allows of the 
counting of the numbers of eggs seen in the 
terminal urine passed in the middle of the day. 
It is possible, therefore, in follow-up surveys 
conducted in the same way to measure the re­
duction in the number of eggs passed per urine 
positive case. Table V  shows the effect of the 
treatment in not only reducing the number of 
urine egg excretions, but also reducing the 
number of eggs passed by each positive case. 
The group which was given intramuscular 
hycanthone consisted of boys and girls in 
the two senior classes in the school and 
at this age, as is usual, the number of eggs pei 
positive case before treatment, is much less than 
is found in children aged 7 to 15 years. It wil 
be seen that less than half the children in eacl 
group treated with one of the oral drugs wen 
free of eggs twelve weeks after the completior 
of the suppressive course of treatment. A mori 
encouraging reduction in the number of egg 
per positive case was noted. The results ii 
urine egg “ cures” and in number of eggs pe: 
positive case is much more encouraging whei 
intramuscular hycanthone was administered.
Cure at 12 weeks after the end of treatment-.
The criterion of “ cure” used in this series wa 
failure to find hatchable eggs in either urine or 
stool. Table V I sets out the results for S. hae­
matobium and S. mansoni infections separately 
even when these were occurring in the same 
individual. Each case was assessed at 12-13 
weeks after the completion of treatment on the 
following criteria:— '
S. haematobium infections:
G.— “ cured” ; less than 100 “ dead”  eggs in 
the sample and no miracidia hatch.
P.— “ improved” ; at least a 90% reduction in 
the egg count, but miracidial hatching 
still occurring.
F. — no change —  a failure.
S. mansoni infections:
G. — “ cured” ; no eggs seen or miracidia
hatched.
P.— “ improved” ; few miracidia hatched, but 
a great reduction in the numbers seen 
and in the number of eggs observed.
F.— little or no change in hatching status.
As would be expected in a trial conducted in 
circumstances where the children were exposed 
to re-infection, even some of those found to be 
free from bilharziasis in the pre-treatment sur-
36
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Table V.
Pre-treatment Survey At 12 weeks after treatment
Group Total eggs
No. of 
positive 
cases
Average 
eggs per 
positive case
Total
Eggs
No. of 
positive 
cases
Average 
eggs per 
positive case
A 73 431 139 528 11 608 86 135
B 55 956 72 777 9 583 45 113
G 43 976 75 586 3 417 43 79
Intramuscular
hycanthone 8 450 44 192 45 3 15
vey were found infected at the follow-up 
examination. These, and children who received 
five doses or less have been excluded from Table 
VI.
The concept of suppressive therapy is not to 
attempt a parasitological cure of the disease 
but to reduce the worm load, the schistosome 
egg output and the tissue damage to the host. 
This is a combination of preventive and per­
sonal health motives which, if effective, might 
go a long way to reducing the infection potential 
in an area. Taking the “ cured” and “ improved” 
categories together; of the oral drugs hycan- 
thone has the best performance against both 
infections.
Performance of oral drugs on patients with 
. double infections:
Table V II shows the effect of suppressive 
therapy on children with double infections of 
S. haematobium and S. mansoni. This small 
group of patients seems to show that there is no 
close relationship between the reaction of the 
drug on both parasites.
Intramuscular hycanthone:
The follow-up results of the group of elder 
children treated with a single intramuscular in­
jection of hycanthone was the most satisfactory 
of all, particularly in respect of S. haematobium 
infections.
Gain in weight:
' In trials of drugs, for the treatment of; bilhar- 
ziasis. it is the rule to weigh patients at each 
follow-up examination.. It was thought that this 
might be a secondary indication of improvement 
in general health following treatment. The 
same procedure was followed' in the-present
trial. The oral treatment groups followed up at 
six months after the commencement of treat­
ment numbered 335, with an average weight 
of 27,5 kg, and they gained 10,9 per cent, in 
weight. The intramuscular treated hycanthone 
group who were, of course, older than the 
previous group, averaged 44,3 kg at the time 
of injection, and also gained 10,9 per cent, in 
weight, which is a more significant gain in older 
children. Untreated children who were also 
weighed numbered only 13 and had an average 
weight of 26,6 kg, showed an 11,1 per cent, gain 
in weight. It appears that the heavier children 
receiving intramuscular hycanthone showed a 
marked increase in weight gain.
Teachers’ observations:
Some of the teachers said that their pupils 
were more attentive and alert at the end of the 
first term and that this improvement was main­
tained throughout the second term of the year 
when the stool and urine follow-up examina­
tions were being carried out. One teacher said 
that- the condition of the skin of the children in 
his class was very much better. A male teacher 
who had the duty of inspecting the cleanliness 
of the boys’ latrines remarked that at the be­
ginning of the term the urinals had to be washed 
down daily to remove the blood stains: in the 
latter part of the term blood staining of the 
urinals had ceased.
D is c u s s io n .
Comparing the three drugs given orally, hy­
canthone (Win 24, 933-2) had the best per­
formance; the immediate patient reaction to the 
tablets was good, perhaps due to, the fact that 
only one small enteric-coated tablet, had to be.
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Table VI.
F o l l o w -U p a t  12 W e e k s  A fter  E nd of T r e a t m e n t : N u m b er  of F ailu res , 
“ C ured”  an d  “ I m proved”  and  Percentage  in  Ea c h  C ateg ory .
Urine Stool
Group C P F T C P F T
A 36 22 33 91 2 13 91 106
39,6 24,2 36,2 100,0 1,9 12,3 85,8 100,0
B .12 14 22 48 2 3 50 55
25,0 29,2 45,8 100,0 3,6 5,4 91,0 100,0
C 20 11 19 50 9 12 26 47
40,0 22,0 38,0 100,0 19,2 25,5 55,3 100,0
Intramuscular 38 3 ■ 1 42 10 9 28 47
hycanthone 90,5 7,1 2,4 100,0 21,3 19,1 59,6 100,0
“ C”  =  Cured “ F”  =  Failure
“ P”  =  Improved “ T ”  =  Total
taken as compared with two large tablets of 
niridazole or lucanthone hydrochloride. The 
later reactions in the hycanthone tablet group 
was more severe than the other two drugs. It 
is not practical to undertake suppressive therapy 
in schools, with drugs administered by the school 
teachers once a week on a dose/weight scale 
and one has to accept a standard dose for all 
the children from the smallest child in the 
school upwards. It will be recalled that it was 
the original intention to administer two oral 
hycanthone tablets of 50 mg each. In fact, two 
tablets caused such serious absenteeism that 
after the first week’s dose it was cut to a single 
tablet. Oral hycanthone has now been with­
drawn and seems unlikely ever to become com­
mercially available and therefore is not likely to 
be used in the future. Niridazole, at the dose 
stated above, was reasonably efficient in S. hae­
matobium, but had a rather poor showing in 
S. mansoni infections. Lees (1968) employed 
lucanthone hydrochloride tablets coated with 
cellulose acetate phthalate which seems to have 
been acceptable to the children in the St. Lucia 
trial as no difficulties in drug administration 
were noted. Using plain tablets of lucanthone 
hydrochloride, the number vomited and second 
tablets refused made a mass administration of 
this form of the drug an unpleasant duty to be 
carried out by school teachers. Children in the 
lower class were found to have great difficulty 
in swallowing the large size tablets of niridazole 
and lucanthone hydrochloride.
’ Su m m a r y .
Children attending a school in a bilharziasis 
endemic area, shown to have high infection
rates of S. haematobium and S. mansoni were 
given a single weekly dose of an oral drug for 
ten weeks of a school term. The drugs used 
were lucanthone hydrochloride, niridazole and 
oral hycanthone. The latter drug had the best 
- showing, both in urinary and stool infections, 
although it appears to have caused more drug 
toxicity and absence from school. Even in S. 
haematobium infections only half the children 
had their condition improved. A  group of 60 
older children who were given a single intra­
muscular injection of hycanthone showed the 
best results in urinary infections.
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